Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Galenica AG ( (CH:GALE) ).
Galenica AG has completed the acquisition of Labor Team, a leading Swiss diagnostic service provider, marking its entry into the diagnostics business. This strategic move will expand Galenica’s health network by integrating innovative laboratory services, strengthening its market position and enhancing healthcare offerings in Switzerland.
The most recent analyst rating on (CH:GALE) stock is a Hold with a CHF92.00 price target. To see the full list of analyst forecasts on Galenica AG stock, see the CH:GALE Stock Forecast page.
More about Galenica AG
Galenica AG is a Swiss company listed on the Swiss stock exchange, specializing in healthcare services and products, including pharmacies, pharmaceutical logistics, and home care. The company is committed to enhancing the Swiss healthcare system through a broad network of services and expertise.
Average Trading Volume: 70,509
Technical Sentiment Signal: Buy
Current Market Cap: CHF4.39B
For a thorough assessment of GALE stock, go to TipRanks’ Stock Analysis page.